Novel Compounds in the Treatment of Schizophrenia—A Selective Review

Schizophrenia is a chronic neuropsychiatric syndrome that significantly impacts daily function and quality of life. All of the available guidelines suggest a combined treatment approach with pharmacologic agents and psychological interventions. However, one in three patients is a non-responder, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsapakis, Evangelia Maria, Diakaki, Kalliopi, Miliaras, Apostolos, Fountoulakis, Konstantinos N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452918/
https://www.ncbi.nlm.nih.gov/pubmed/37626549
http://dx.doi.org/10.3390/brainsci13081193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452918/
https://www.ncbi.nlm.nih.gov/pubmed/37626549
http://dx.doi.org/10.3390/brainsci13081193

Ejemplares similares